Atezolizumab,Bevacizumab
Roche
['tecentriq', 'roche,(-broche),(-rocheter)']
a negative early sign of patient deaths in roche's landmark tecentriq early-stage liver cancer data might raise some eyebrows, and it could force a delay at the fda. #aacr23 
Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox. Follow ‘The Top Line’ podcast.